<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04775888</url>
  </required_header>
  <id_info>
    <org_study_id>2020PHAREO</org_study_id>
    <nct_id>NCT04775888</nct_id>
  </id_info>
  <brief_title>Accessibility of Prophylaxis and On-demand Treatment for Persons With Haemophilia and Other Coagulation Deficiencies</brief_title>
  <acronym>PHAREO</acronym>
  <official_title>Prophylaxis and On-demand Treatment for Persons With Haemophilia and Other Coagulation Deficiencies: a Comparison of Perceived and Observed Accessibility in the Auvergne-Rhône-Alpes Region (France)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RESCUe - RESeau Cardiologie Urgence / RESUVal - RESeau des Urgences de la vallée du Rhône</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>RESCUe - RESeau Cardiologie Urgence / RESUVal - RESeau des Urgences de la vallée du Rhône</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current treatment of people with haemophilia and other bleeding deficiencies is largely&#xD;
      based on clotting factor replacement therapy. The injections can be repeated several times a&#xD;
      week according to a personalized schedule. To date, medications are exclusively dispensed in&#xD;
      hospital pharmacies to ensure traceability and safety. This retrocession imposes&#xD;
      accessibility constraints on patients and on their caregivers, increasing the burden of the&#xD;
      disease, particularly in the organization of personal and professional daily life. The PHAREO&#xD;
      study aims to investigate patients' perception of accessibility to anti-haemophilia drugs in&#xD;
      relation to an evaluation of spatial accessibility in the Auvergne-Rhône-Alpes region&#xD;
      (France) in order to consider, if necessary, ways of improving the pathway for patients and&#xD;
      their caregivers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Haemophilia is a rare constitutional hemorrhagic disease whose drug management is based on&#xD;
      the use of chronic lifelong replacement therapy. For many years, the reference treatment,&#xD;
      particularly in children, has been based on the use of anti-haemophilic drugs for prophylaxis&#xD;
      requiring repeated injections several times a week according to a personalized schedule. In&#xD;
      contrast, on-demand treatment is less and less used, particularly in patients with severe&#xD;
      forms of haemophilia. Clinical and biological diagnosis, as well as the implementation and&#xD;
      monitoring of treatments, are carried out within specialized hospital care structures&#xD;
      affiliated with the French national reference center. Medications are dispensed as part of&#xD;
      hospital retrocessions. This organization imposes constraints on patients and their&#xD;
      caregivers due to their limited accessibility.&#xD;
&#xD;
      The burden related to this disease is probably due to the systematic use of specialized&#xD;
      hospital teams such as doctors, nurses for self-injection training for example, and&#xD;
      pharmacists. It now seems important to reflect on the evolution of patient pathways that were&#xD;
      previously exclusively hospital-centred towards ambulatory care. To do this, various&#xD;
      reflections need to be undertaken, including that relating to the accessibility of&#xD;
      medication. Indeed, the monthly renewals of these chronic treatments force patients and their&#xD;
      caregivers, as well as the parents of children, to go to the hospital, which frequently makes&#xD;
      the organization of daily and professional life more cumbersome.&#xD;
&#xD;
      The PHAREO study aims to investigate patients' perception of accessibility to&#xD;
      anti-haemophilia drugs in relation to an evaluation of spatial accessibility in order to&#xD;
      consider, if necessary, ways of improving the pathway for patients and their caregivers.&#xD;
&#xD;
      The expected benefits of the study are to have: 1) an exhaustive description of the spatial&#xD;
      accessibility of the cohort of people living with haemophilia to anti-haemophilia medication&#xD;
      within the Auvergne Rhône Alpes region (France) and 2) a better understanding of their needs&#xD;
      and their perceptions regarding access to on-demand and prophylactic treatments.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 21, 2020</start_date>
  <completion_date type="Anticipated">May 21, 2021</completion_date>
  <primary_completion_date type="Actual">April 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the perception of persons with haemophilia and other coagulation deficiencies regarding the accessibility to prophylactic and on-demand antihemorrhagic treatment</measure>
    <time_frame>Through study completion, on average 6 months.</time_frame>
    <description>The perception is defined by the satisfaction level of the survey participants, measured with on item in the questionnaire (Very satisfied / Rather satisfied / Rather not satisfied / Not satisfied).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To measure the accessibility of persons with haemophilia and other coagulation deficiencies regarding the accessibility to prophylactic and on-demand antihemorrhagic treatment</measure>
    <time_frame>Through study completion, on average 6 months.</time_frame>
    <description>The accessibility is measured by spatial analysis, representing the distance between the home and/or work zip codes and the hospital pharmacy zip code.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>To compare the perception and the spatial accessibility of persons with haemophilia and other coagulation deficiencies regarding prophylactic and on-demand antihemorrhagic treatment</measure>
    <time_frame>Through study completion, on average 6 months.</time_frame>
    <description>The mean distances between the 4-groups of satisfaction level are compared using an analysis of variance (ANOVA).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To determine if the severity of the disease would be a factor for encouraging or limiting the perception of accessibility to prophylactic or on-demand anti-haemorrhagic treatments</measure>
    <time_frame>Through study completion, on average 6 months.</time_frame>
    <description>The satisfaction level of participants are stratified on the severity of the disease (minor, moderate, major).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine if the age of the patient would be a factor for encouraging or limiting the perception of accessibility to prophylactic or on-demand anti-haemorrhagic treatments</measure>
    <time_frame>Through study completion, on average 6 months.</time_frame>
    <description>The satisfaction level of participants are stratified on the age of patient.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine if the condition of access to hospital would be a factor for encouraging or limiting the perception of accessibility to prophylactic or on-demand anti-haemorrhagic treatments</measure>
    <time_frame>Through study completion, on average 6 months.</time_frame>
    <description>The satisfaction level of participants are stratified on the condition of access to hospital (relative to traffic conditions, the physical condition of the patient, the parking difficulties).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine if the level of autonomy of the participant would be a factor for encouraging or limiting the perception of accessibility to prophylactic or on-demand anti-haemorrhagic treatments</measure>
    <time_frame>Through study completion, on average 6 months.</time_frame>
    <description>The satisfaction level of participants are stratified on the level of autonomy of the participant (relative to wheelchair, crutch/walking stick or other mobility aid).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine if the availability of the hospital pharmacy would be a factor for encouraging or limiting the perception of accessibility to prophylactic or on-demand anti-haemorrhagic treatments</measure>
    <time_frame>Through study completion, on average 6 months.</time_frame>
    <description>The satisfaction level of participants are stratified on the availability of the hospital pharmacy (relative to the waiting times).</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Health Services Accessibility</condition>
  <condition>Blood Coagulation Factor Deficiencies</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The included subjects comprise people with haemophilia or other coagulation deficiencies,&#xD;
        with no limitation of age, treated by prophylaxis or on-demand treatment, in one of the&#xD;
        authorized hospital pharmacies in the Auvergne-Rhone-Alpes region (France).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Included:&#xD;
&#xD;
          -  Living person on the study start date and presenting with haemophilia or other&#xD;
             coagulation deficiencies;&#xD;
&#xD;
          -  Treated with prophylaxis or on-demand anti-haemorrhagic treatments;&#xD;
&#xD;
          -  Location of medication dispensing within the hospital pharmacies of the HEsora network&#xD;
             (Hémophilie Soins Rhône Alpes): 27 eligible hospital pharmacies in Rhône Alpes + &lt;10&#xD;
             eligible hospital pharmacies in Auvergne&#xD;
&#xD;
        Excluded:&#xD;
&#xD;
        - Home delivery (not included in the study via hospital pharmacy)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurie Fraticelli, PhD</last_name>
    <role>Study Director</role>
    <affiliation>RESCUe-RESUVal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julie Freyssenge, PhD</last_name>
    <role>Study Director</role>
    <affiliation>RESCUe-RESUVal</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Valérie Chamouard, PharmD</last_name>
    <phone>+33(0)472118829</phone>
    <email>valerie.chamouard@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carlos El Khoury, MD, PhD</last_name>
    <phone>+33(0)437021059</phone>
    <email>c.elkhoury@resuval.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Albertville-Moûtiers</name>
      <address>
        <city>Albertville</city>
        <zip>73200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Gailland</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Annecy Genevois</name>
      <address>
        <city>Annecy</city>
        <zip>74370</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christelle Roch</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier d'Ardèche Nord</name>
      <address>
        <city>Annonay</city>
        <zip>07103</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie Vernardet</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier d'Ardèche Méridionale</name>
      <address>
        <city>Aubenas</city>
        <zip>07200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain Lenoir</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Henri Mondor d'Aurillac</name>
      <address>
        <city>Aurillac</city>
        <zip>15000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valérie Millot</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Belley</name>
      <address>
        <city>Belley</city>
        <zip>01300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Geneste</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier de Bourg St Maurice</name>
      <address>
        <city>Bourg St Maurice</city>
        <zip>73700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valérie Chaminant</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Fleyriat</name>
      <address>
        <city>Bourg-en-Bresse</city>
        <zip>01012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphanie Claveranne</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Pierre Oudot</name>
      <address>
        <city>Bourgoin-Jallieu</city>
        <zip>38300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clément Beyron</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Groupement Hospitalier Est, Hospices Civils de Lyon</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valérie Chamouard</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Chambéry - Hôpital Savoie</name>
      <address>
        <city>Chambéry</city>
        <zip>73000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elodie Bernard</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Boyer</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Alpes Léman</name>
      <address>
        <city>Contamine-sur-Arve</city>
        <zip>74130</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Diakhate</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Nord Ouest de Villefranche-sur-Saône</name>
      <address>
        <city>Gleizé</city>
        <zip>69400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magali Bourdelin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Grenoble - Alpes</name>
      <address>
        <city>La Tronche</city>
        <zip>38700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie Cerena</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Edouard herriot, Hospices Civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elodie Lanoi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Croix-Rousse, Hospices Civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Claire Uhrès</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier du Forez</name>
      <address>
        <city>Montbrison</city>
        <zip>42600</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hadyl Asfari</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de Montluçon</name>
      <address>
        <city>Montluçon</city>
        <zip>03100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carole Rimpici</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Montélimar</name>
      <address>
        <city>Montélimar</city>
        <zip>26200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jérémy Rolain</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Moulins-Yzeure</name>
      <address>
        <city>Moulins</city>
        <zip>03006</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel Deligeard</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Du Haut Bugey</name>
      <address>
        <city>Oyonnax</city>
        <zip>01100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathalie Dey</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier des Vals d'Ardeche</name>
      <address>
        <city>Privas</city>
        <zip>07007</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique Quinard</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Roanne</name>
      <address>
        <city>Roanne</city>
        <zip>42300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maud Rossignol</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Drôme Nord</name>
      <address>
        <city>Romans-sur-Isère</city>
        <zip>26100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Cussoneau</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pharmacie Centrale, Hospices Civils de Lyon</name>
      <address>
        <city>Saint-Genis-Laval</city>
        <zip>69230</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle Carpentier</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal Sud-Léman Valserine</name>
      <address>
        <city>Saint-Julien-en-Genevois</city>
        <zip>74164</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandra Combes</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Uuniversitaire Nord, Saint-Étienne</name>
      <address>
        <city>Saint-Priest-en-Jarez</city>
        <zip>42270</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jihen Boussetta</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpitaux du Pays du Mont-Blanc</name>
      <address>
        <city>Sallanches</city>
        <zip>74700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marion Filippi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Nord-Ouest Tarare-Grandris</name>
      <address>
        <city>Tarare</city>
        <zip>69170</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Vray</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopitaux du Léman</name>
      <address>
        <city>Thonon-les-Bains</city>
        <zip>74203</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denis Hardelin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Valence</name>
      <address>
        <city>Valence</city>
        <zip>26000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphanie Bourget</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Vichy</name>
      <address>
        <city>Vichy</city>
        <zip>03200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jérôme Tavernier</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Lucien Hussel</name>
      <address>
        <city>Vienne</city>
        <zip>38200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Sophie Leromain</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Leroy V, Freyssenge J, Renard F, Tazarourte K, Négrier C, Chamouard V. Access to treatment among persons with hemophilia: A spatial analysis assessment in the Rhone-Alpes region, France. J Am Pharm Assoc (2003). 2019 Nov - Dec;59(6):797-803. doi: 10.1016/j.japh.2019.07.006. Epub 2019 Aug 9.</citation>
    <PMID>31405805</PMID>
  </reference>
  <reference>
    <citation>Susen S, Gruel Y, Godier A, Harroche A, Chambost H, Lasne D, Rauch A, Roullet S, Fontana P, Goudemand J, de Maistre E, Chamouard V, Wibaut B, Albaladejo P, Négrier C. Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra(®) ): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP). Haemophilia. 2019 Sep;25(5):731-737. doi: 10.1111/hae.13817. Epub 2019 Jul 11. Review.</citation>
    <PMID>31294904</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 11, 2021</study_first_submitted>
  <study_first_submitted_qc>February 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2021</study_first_posted>
  <last_update_submitted>May 13, 2021</last_update_submitted>
  <last_update_submitted_qc>May 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>haemophilia</keyword>
  <keyword>accessibility</keyword>
  <keyword>on-demand treatment</keyword>
  <keyword>prophylactic treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemophilia A</mesh_term>
    <mesh_term>Coagulation Protein Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Patient information is held under legal and ethical obligations of confidentiality. As the disease is rare, information should not be used or disclosed in a form that might identify a patient without his or her consent.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

